<DOC>
	<DOCNO>NCT00236509</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy three dos topiramate ( 50 milligram [ mg ] , 100mg , 200mg take daily ) compare placebo prevention migraine .</brief_summary>
	<brief_title>A Study Efficacy Safety Topiramate Prevention Migraine</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , parallel-group , multi-center study evaluate effectiveness safety three different dos topiramate ( 50mg , 100mg , 200mg daily ) migraine prophylaxis . The study consist five phase : baseline ( determination whether patient meet eligibility criterion taper migraine medication patient already take ) ; initial titration double-blind phase ( 8 week ) begin 25 mg/daily increase assign ( 50 , 100 , 200 mg/day topiramate ) ; follow maintenance period target dose ( 18 week ) ; taper transition phase ( 7 week ) ; open-label extension 6 month ( maximum topiramate dose 1600 mg/day ) ; dos adjust maximize effectiveness minimize side effect . The primary study hypothesis one three dos topiramate ( 50 , 100 , 200 mg/day ) superior placebo prophylaxis migraine base change monthly ( 28 day ) migraine period rate prospective baseline period double-blind phase topiramate treatment well tolerate . During titration period ( 8 week ) , dose increase target dose daily topiramate ( 50 milligram [ mg ] , 100 , 200mg ) placebo , take twice daily mouth . Doses continued 18 week , adjust 7 week , continue 6 month Open-Label Extension .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Medical history consistent migraine without aura accord International Headache Society ( IHS ) least 6 month prior study Between 3 12 migraine period great 15 headache day ( migraine nonmigraine ) per month Baseline Phase No clinically significant abnormality neurological exam , electrocardiogram ( ECG ) clinical laboratory test result baseline Female patient must postmenopausal least 1 year , surgically incapable childbearing , practice abstinence , practice acceptable method contraception ( require negative pregnancy test ) Patients headache migraine Patients episodic tension sinus headache Onset migraine age 50 year Patients fail two adequate regimen migraine prophylaxis Patients overuse pain medication certain medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Common Migraine</keyword>
	<keyword>Classic Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>